This compound is primarily utilized in pharmaceutical research, particularly in the development of enzyme inhibitors. It has shown potential in targeting specific enzymes involved in inflammatory and metabolic disorders. Its unique structure allows it to interact with enzyme active sites, making it a candidate for drug development in conditions like diabetes and autoimmune diseases. Additionally, its fluorophenyl and benzyloxy groups contribute to its stability and binding affinity, enhancing its efficacy in preclinical studies. Researchers are exploring its use in creating novel therapeutic agents with improved selectivity and reduced side effects.